全癌症T细胞图谱将细胞应激反应状态与免疫疗法耐药性联系起来
Yanshuo Chu1, Enyu Dai1, Yating Li1,2
1Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Nature medicine
|May 29, 2023
概括
这项研究揭示了瘤中的新型T细胞状态,包括与免疫治疗耐药性相关的应激反应状态 (TSTR). 这些发现为优化癌症治疗和发现生物标志物提供了新的目标.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 基因组学就是基因组学.
背景情况:
- 瘤透T细胞对癌症免疫至关重要,但它们的不同状态尚未完全理解.
- 描述T细胞异质性是促进癌症免疫疗法的关键.
研究的目的:
- 在16种癌症类型中创建一个全面的T细胞单细胞地图.
- 确定新的T细胞状态和亚群及其临床相关性.
- 调查T细胞状态对免疫检查点阻塞疗法的反应中的作用.
主要方法:
- 来自16种癌症类型的308,048个T细胞的单细胞RNA测序.
- 在瘤微环境中检测T细胞状态.
- 对T细胞状态与375名患者的基因组,病理和临床数据的相关性分析.
主要成果:
- 发现以前未被描述的T细胞状态,包括由热冲击基因表达标记的应激反应状态 (TSTR).
- 在各种癌症中发现了TSTR细胞,通常在淋巴状结构附近.
- 与患者特征和免疫检查点阻塞反应相关的T细胞状态,在不响应的瘤中增加了热冲击基因表达.
结论:
- "T细胞地图"为优化T细胞治疗提供了有价值的参考地图.
- TSTR细胞可能在免疫疗法耐药性中发挥作用,表明潜在的治疗点.
- 开发的工具有助于T细胞研究和生物标志物发现,以改善癌症治疗.
更多相关视频
06:16Generation of Orthotopic Pancreatic Tumors and Ex vivo Characterization of Tumor-Infiltrating T Cell Cytotoxicity
Published on: December 7, 2019
12.8K
08:30Immunophenotyping of Orthotopic Homograft Syngeneic of Murine Primary KPC Pancreatic Ductal Adenocarcinoma by Flow Cytometry
Published on: October 9, 2018
12.4K
相关概念视频
Tumor Immunotherapy
577
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
577
Psychoneuroimmunology: Diabetes and Cancer
50
Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
50
Adaptive Mechanisms in Cancer Cells
5.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Interactions Between Signaling Pathways
6.3K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
